Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31700162)

  • 1. Three-dimensional visualization of cleared human pancreas cancer reveals that sustained epithelial-to-mesenchymal transition is not required for venous invasion.
    Hong SM; Jung D; Kiemen A; Gaida MM; Yoshizawa T; Braxton AM; Noë M; Lionheart G; Oshima K; Thompson ED; Burkhart R; Wu PH; Wirtz D; Hruban RH; Wood LD
    Mod Pathol; 2020 Apr; 33(4):639-647. PubMed ID: 31700162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent Intraluminal Growth of Large Muscular Veins in Surgically Resected Colorectal Cancer Tissues: A 3-Dimensional Pathologic Reconstruction Study.
    Jung D; Shin J; Park J; Shin J; Sung YN; Kim Y; Yoo S; Lee BW; Jang SW; Park IJ; Wood LD; Pack CG; Hruban RH; Hong SM
    Mod Pathol; 2023 Mar; 36(3):100082. PubMed ID: 36788099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmin and CD31 immunolabeling for detecting venous invasion of the pancreatobiliary tract cancers.
    Shin J; Wood LD; Hruban RH; Hong SM
    PLoS One; 2020; 15(11):e0242571. PubMed ID: 33253282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological tumor invasion of the mesenterico-portal vein is characterized by aggressive biology and stromal fibroblast activation.
    Lapshyn H; Bolm L; Kohler I; Werner M; Billmann FG; Bausch D; Hopt UT; Makowiec F; Wittel UA; Keck T; Bronsert P; Wellner UF
    HPB (Oxford); 2017 Jan; 19(1):67-74. PubMed ID: 27825542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma: Characterization in a 3D-cell culture model.
    Gagliano N; Celesti G; Tacchini L; Pluchino S; Sforza C; Rasile M; Valerio V; Laghi L; Conte V; Procacci P
    World J Gastroenterol; 2016 May; 22(18):4466-83. PubMed ID: 27182158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive histological evaluation with clinical analysis of venous invasion in pancreatic ductal adenocarcinoma: From histology to clinical implications.
    Lee SJ; Sung YN; Kim SJ; Shin S; Cho H; Hruban RH; Hong SM
    Pancreatology; 2020 Oct; 20(7):1486-1494. PubMed ID: 32948429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancerization of the Pancreatic Ducts: Demonstration of a Common and Under-recognized Process Using Immunolabeling of Paired Duct Lesions and Invasive Pancreatic Ductal Adenocarcinoma for p53 and Smad4 Expression.
    Hutchings D; Waters KM; Weiss MJ; Wolfgang CL; Makary MA; He J; Cameron JL; Wood LD; Hruban RH
    Am J Surg Pathol; 2018 Nov; 42(11):1556-1561. PubMed ID: 30212393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunolabeling of Cleared Human Pancreata Provides Insights into Three-Dimensional Pancreatic Anatomy and Pathology.
    Noë M; Rezaee N; Asrani K; Skaro M; Groot VP; Wu PH; Olson MT; Hong SM; Kim SJ; Weiss MJ; Wolfgang CL; Makary MA; He J; Cameron JL; Wirtz D; Roberts NJ; Offerhaus GJA; Brosens LAA; Wood LD; Hruban RH
    Am J Pathol; 2018 Jul; 188(7):1530-1535. PubMed ID: 29684363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinoma.
    Cates JM; Byrd RH; Fohn LE; Tatsas AD; Washington MK; Black CC
    Pancreas; 2009 Jan; 38(1):e1-6. PubMed ID: 18766116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoplastic spindle cells are an independent prognostic factor in pancreatic cancer.
    Takahashi K; Hisaka T; Horiuchi H; Ishikawa H; Nakayama M; Nakashima O; Kawahara A; Kage M; Yano H; Akagi Y; Yonemoto K; Kinoshita H; Shirouzu K
    Pancreas; 2015 Jul; 44(5):742-9. PubMed ID: 25931259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients.
    Guo S; Jing W; Hu X; Zhou X; Liu L; Zhu M; Yin F; Chen R; Zhao J; Guo Y
    Int J Cancer; 2014 Mar; 134(6):1369-78. PubMed ID: 24037692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 accumulation confers prognostic information in resectable adenocarcinomas with ductal but not with intestinal differentiation in the pancreatic head.
    Bergan A; Gladhaug IP; Schjolberg A; Bergan AB; Clausen OP
    Int J Oncol; 2000 Nov; 17(5):921-6. PubMed ID: 11029493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal-epithelial transition of pancreatic cancer cells at perineural invasion sites is induced by Schwann cells.
    Fujii-Nishimura Y; Yamazaki K; Masugi Y; Douguchi J; Kurebayashi Y; Kubota N; Ojima H; Kitago M; Shinoda M; Hashiguchi A; Sakamoto M
    Pathol Int; 2018 Apr; 68(4):214-223. PubMed ID: 29457853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
    Tachezy M; Reichelt U; Melenberg T; Gebauer F; Izbicki JR; Kaifi JT
    Histol Histopathol; 2010 Oct; 25(10):1239-46. PubMed ID: 20712008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why is pancreatic cancer so deadly? The pathologist's view.
    Hruban RH; Gaida MM; Thompson E; Hong SM; Noë M; Brosens LA; Jongepier M; Offerhaus GJA; Wood LD
    J Pathol; 2019 Jun; 248(2):131-141. PubMed ID: 30838636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma.
    Kohler I; Bronsert P; Timme S; Werner M; Brabletz T; Hopt UT; Schilling O; Bausch D; Keck T; Wellner UF
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():78-84. PubMed ID: 25827809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of E-cadherin expression and outcome among patients with resectable pancreatic adenocarcinomas.
    Hong SM; Li A; Olino K; Wolfgang CL; Herman JM; Schulick RD; Iacobuzio-Donahue C; Hruban RH; Goggins M
    Mod Pathol; 2011 Sep; 24(9):1237-47. PubMed ID: 21552209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TM4SF1 as a prognostic marker of pancreatic ductal adenocarcinoma is involved in migration and invasion of cancer cells.
    Zheng B; Ohuchida K; Cui L; Zhao M; Shindo K; Fujiwara K; Manabe T; Torata N; Moriyama T; Miyasaka Y; Ohtsuka T; Takahata S; Mizumoto K; Oda Y; Tanaka M
    Int J Oncol; 2015 Aug; 47(2):490-8. PubMed ID: 26035794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BACH1 Promotes Pancreatic Cancer Metastasis by Repressing Epithelial Genes and Enhancing Epithelial-Mesenchymal Transition.
    Sato M; Matsumoto M; Saiki Y; Alam M; Nishizawa H; Rokugo M; Brydun A; Yamada S; Kaneko MK; Funayama R; Ito M; Kato Y; Nakayama K; Unno M; Igarashi K
    Cancer Res; 2020 Mar; 80(6):1279-1292. PubMed ID: 31919242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
    Meng F; Li W; Li C; Gao Z; Guo K; Song S
    Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.